Walmart Inc (NASDAQ: WMT) closed Friday at $127.50, up 2.15 percent on the session as the broader market extended its record-breaking week, with the retail giant consolidating near the top end of its recent trading range and a market capitalisation hovering just above $1 trillion.
The company has been busy on multiple operational fronts. It announced this month that it is investing in remodels at more than 650 stores across the United States, with roughly 20 new locations also planned to open in 2026 and early 2027. The rollout spans states including Florida, Texas, California, Georgia and South Carolina among others, with each wave of announcements framed around improving in-store convenience, digital integration and the customer experience for both physical and online shoppers.
On the health side, Walmart is expanding what it calls its Better Care Services platform, adding weight management support offerings to its existing pharmacy and optical footprint. The move puts it more directly in competition with pharmacy chains and health insurers as the GLP-1 weight loss drug market continues to reshape consumer healthcare spending patterns, with Walmart’s scale in everyday foot traffic giving it a potentially significant edge in converting shoppers into health service customers.
The company is also moving deeper into live event ticketing, with reports indicating exploratory efforts to compete in a segment currently dominated by Ticketmaster and its parent Live Nation. The strategic logic is consistent with Walmart’s broader push to keep customers engaged with the brand across more categories of spending, and would complement its expanding financial services and digital payments infrastructure.
Guggenheim raised its price target on WMT to $137 from $120 in April, and the 29-analyst consensus sits at a Strong Buy with a $133.69 average price target implying around 4.7 percent additional upside from Friday’s close. FY2026 revenue of $713.16 billion was up 4.73 percent year on year, with net income of $21.89 billion representing 12.64 percent growth, metrics that underscore the durability of the earnings model even as the stock trades at a P/E of around 47 times trailing earnings. The next earnings report is due May 14.
